CBAY

Cymabay Therapeutics
CBAY

Overview Fund Activity
Delisted

CBAY was delisted on the 21st of March, 2024.

Back to rankings

142 hedge funds and large institutions have $907M invested in Cymabay Therapeutics in 2019 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 35 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
142
Holders Change
+11
Holders Change %
+8.4%
% of All Funds
3.08%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
26
Increased
48
Reduced
35
Closed
15
Calls
$1.62M
Puts
$852K
Net Calls
+$766K
Net Calls Change
+$970K

Top Buyers

1
O
OrbiMed
New York
+$24.9M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$24.1M
3
PA
Perceptive Advisors
New York
+$23.2M
4
Citadel Advisors
Citadel Advisors
Florida
+$18.3M
5
VC
Vivo Capital
California
+$15.3M

Top Sellers

1
BC
Boxer Capital
California
-$11.2M
2
DM
Deerfield Management
New York
-$10.6M
3
Franklin Resources
Franklin Resources
California
-$8.11M
4
NC
Nexthera Capital
New York
-$6.7M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.64M
Name Holding Trade Value Shares
Change 		Shares
Change %
FI
26
Fosun International
China
$10.5M – – –
Geode Capital Management
27
Geode Capital Management
Massachusetts
$10.3M +$2M +150,453 +24%
GTC
28
Ghost Tree Capital
New York
$9.96M +$9.96M +750,000 New
Northern Trust
29
Northern Trust
Illinois
$9.82M +$424K +31,914 +5%
ACA
30
Avoro Capital Advisors
New York
$9.63M +$9.63M +725,000 New
RSCM
31
Rock Springs Capital Management
Maryland
$9.5M +$1.35M +101,396 +17%
AG
32
Artal Group
Luxembourg
$7.97M +$1.33M +100,000 +20%
UBS AM
33
UBS AM
Illinois
$7.58M +$468K +35,223 +7%
OFM
34
Omega Fund Management
Massachusetts
$7.32M – – –
OM
35
Opaleye Management
Massachusetts
$7.3M -$2.32M -175,000 -24%
ACP
36
Acuta Capital Partners
California
$6.87M +$6.87M +517,500 New
Charles Schwab
37
Charles Schwab
California
$4.85M +$549K +41,319 +13%
SFM
38
Sphera Funds Management
Israel
$4.59M +$4.59M +345,535 New
SSA
39
Schonfeld Strategic Advisors
New York
$4.03M +$3.73M +281,200 +1,267%
JPMorgan Chase & Co
40
JPMorgan Chase & Co
New York
$3.94M -$255K -19,223 -6%
State of Wisconsin Investment Board
41
State of Wisconsin Investment Board
Wisconsin
$3.89M -$220K -16,582 -5%
DCM
42
DAFNA Capital Management
California
$3.7M -$713K -53,700 -16%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$3.43M +$141K +10,587 +4%
SCM
44
Sio Capital Management
New York
$3.19M +$697K +52,500 +28%
TCIM
45
TIAA CREF Investment Management
New York
$3.03M +$827K +62,275 +38%
HM
46
HealthCor Management
New York
$2.98M +$2.98M +224,640 New
B
47
Bailard
California
$2.86M +$1.2M +90,100 +72%
Deutsche Bank
48
Deutsche Bank
Germany
$2.82M +$1.98M +149,388 +238%
NC
49
Nexthera Capital
New York
$2.79M -$6.7M -504,507 -71%
Goldman Sachs
50
Goldman Sachs
New York
$2.78M +$1.53M +114,946 +122%
1
2
3 4 5